Intermediate-Risk Newly Diagnosed Metastatic Renal Cell Carcinoma
EP. 1: Case Overview: Newly Diagnosed mRCC
Watch
EP. 2: Considerations When Treating Newly Diagnosed mRCC
EP. 3: New Therapy Options in Newly Diagnosed mRCC
EP. 4: Treatment Goals in Newly Diagnosed mRCC
EP. 5: First-Line Targeted Therapy in mRCC
EP. 6: Strategies for Managing VEGF-TKI Toxicities
EP. 7: Cabozantinib in mRCC
